(Q45863908)

17 December 2017

title

Treatment of hemophilia: recombinant factors only? Yes. (English)

1 reference

17 December 2017

0 references

Giangrande PL

1

1 reference

17 December 2017

publication date

1 February 2003

1 reference

17 December 2017

Journal of Thrombosis and Haemostasis

published in

1 reference

17 December 2017

volume

1

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

214-215

1 reference

17 December 2017

TT virus contaminates first-generation recombinant factor VIII concentrates

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

Risk of variant Creuzfeldt-Jakob disease from factor concentrates: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

Transmission of prion diseases by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00049.X

10.1046/J.1538-7836.2003.00049.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

release_ub5iovu6jfdo7g4qg7e4qffo6q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ub5iovu6jfdo7g4qg7e4qffo6q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 December 2017